High incidence of tuberculin skin test conversion among HIV-infected individuals who have a favourable immunological response to highly active antiretroviral therapy.

A total of 129 HIV-infected individuals who were tuberculin skin test (TST) negative in 1997 and started highly active antiretroviral therapy (HAART) after skin testing, received a second TST during 2000. Seven patients converted to a positive TST. In multivariate analysis, an increase in CD4 T lymphocyte count more than 200 × 10 6 /1 over baseline was significantly associated with TST conversion. TST should be repeated in TST-negative HIV-infected individuals who experience an immunological response to HAART.

[1]  P. Pezzotti,et al.  Different pattern of AIDS-defining diseases in persons responding to highly active antiretroviral therapy. , 2001 .

[2]  C. Hung,et al.  Restoration of Cellular Immunity Against Tuberculosis in Patients Coinfected With HIV‐1 and Tuberculosis With Effective Antiretroviral Therapy: Assessment by Determination of CD69 Expression on T Cells After Tuberculin Stimulation , 2000, Journal of acquired immune deficiency syndromes.

[3]  G. Ippolito,et al.  Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection , 2000, AIDS.

[4]  M. Lederman,et al.  Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen , 2000, AIDS.

[5]  H. Furrer,et al.  HAART in HIV-infected patients: restoration of antigen-specific CD4 T-cell responses in vitro is correlated with CD4 memory T-cell reconstitution, whereas improvement in delayed type hypersensitivity is related to a decrease in viraemia. , 1999, AIDS.

[6]  R. Paganelli,et al.  Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease. , 1999, AIDS.

[7]  M. Narita,et al.  Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. , 1998, American journal of respiratory and critical care medicine.

[8]  P. Kvale,et al.  Incidence of Tuberculosis in the United States among HIV-Infected Persons , 1997, Annals of Internal Medicine.

[9]  G. Ippolito,et al.  Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA). , 1995, JAMA.

[10]  D. Vlahov,et al.  Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users. , 1992, JAMA.